Xencor, Inc. (XNCR)
NASDAQ: XNCR · Real-Time Price · USD
35.77
+1.72 (5.05%)
At close: Nov 6, 2026, 4:00 PM EST
35.76
-0.01 (-0.03%)
After-hours: Nov 6, 2026, 5:12 PM EST
Xencor Market Cap
Xencor has a market cap or net worth of $2.68 billion as of November 6, 2026. It is the 5,613th most valuable company in the world and the 1,590th biggest in the United States. Its market cap has increased by 161.56% in one year.
Market Cap
2.68B
Enterprise Value
2.26B
1-Year Change
161.56%
Global Rank
Country Rank
#1,590 United States
Category
ChartMarket Cap Chart
Since December 3, 2013, Xencor's market cap has increased from $245.40M to $2.68B, an increase of 993.79%. That is a compound annual growth rate of 20.32%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 6, 2026 | 2.68B | 145.51% |
| Dec 31, 2025 | 1.09B | -32.02% |
| Dec 31, 2024 | 1.61B | 24.44% |
| Dec 29, 2023 | 1.29B | -17.18% |
| Dec 30, 2022 | 1.56B | -33.50% |
| Dec 31, 2021 | 2.35B | -6.40% |
| Dec 31, 2020 | 2.51B | 28.51% |
| Dec 31, 2019 | 1.95B | -4.07% |
| Dec 31, 2018 | 2.03B | 97.53% |
| Dec 29, 2017 | 1.03B | -4.93% |
| Dec 30, 2016 | 1.08B | 82.97% |
| Dec 31, 2015 | 591.80M | 17.51% |
| Dec 31, 2014 | 503.60M | 87.28% |
| Dec 31, 2013 | 268.90M | 9.58% |
| Dec 3, 2013 | 245.40M | - |
View and export this data all the way back to 2013. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| MBX Biosciences | 2.53B |
| ADMA Biologics | 2.52B |
| NewAmsterdam Pharma Company | 2.47B |
| Pharvaris | 2.41B |
| Aurinia Pharmaceuticals | 2.33B |
| Biohaven | 2.32B |
| Celldex Therapeutics | 2.31B |
| Recursion Pharmaceuticals | 2.30B |